Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
BioSante Says Leukemia Vaccine Shows Promise In Study
(Reuters) Mar 11, 2010 - BioSante Pharmaceuticals Inc said a small study showed its GVAX leukemia vaccine may be able to reduce or eliminate the remaining cancer cells in some chronic myeloid leukemia (CML) patients taking cancer drug Gleevec, sending its shares up 22 percent.
read article 
Personalized Medicine Spurred by Medco’s Cost-Saving Gene Tests
(Bloomberg) Mar 11, 2010 - Medco Health Solutions Inc., the second-biggest U.S. manager of drug benefits, is encouraging doctors to use genetic tests to determine whether drugs will work for particular patients -- saving money and reducing harm caused when prescriptions are wrong.
read article
Scientists Find Key to Hormone-Resistant Prostate Tumors
(BusinessWeek.com) Mar 10, 2010 - Though hormone therapy has proven useful in treating late-stage prostate cancer, it often results in the development of fatal secondary tumors that are resistant to such therapy.
read article
Disease Cause Is Pinpointed With Genome
(New York Times) Mar 10, 2010 - Two research teams have independently decoded the entire genome of patients to find the exact genetic cause of their diseases. The approach may offer a new start in the so far disappointing effort to identify the genetic roots of major killers like heart disease, diabetes and Alzheimer’s.
read article (free registration required)
Tumors May Respond to Extreme and Moderate Heat
(AACR) Mar 10, 2010 - Aided by ultrasound guidance, treating tumors with extreme heat or moderate heat may provide a possible therapeutic option, according to early research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held March 7-10, 2010.
read press release
FDA Will Review Fosamax, Boniva for Safety
(Wall Street Journal) Mar 11, 2010 - The Food and Drug Administration said Wednesday it's conducting a safety review of certain bone-building drugs like Fosamax and Boniva to see if they increase the risk of femur fractures.
read article (paid subscription required)
Cancer Deaths Down Since 'War on Cancer'
(WebMD) Mar 10, 2010 - The U.S. is making gains on at least one war front, the "War on Cancer," according to a new analysis of cancer death statistics.
read article
Despite Law, Drug Safety Still A Concern At FDA
(Reuters) Mar 10, 2010 - Recent new powers have helped the U.S. Food and Drug Administration combat contaminated medications, counterfeit pills and other safety woes, but more work is needed to address lingering concerns about drug risks, FDA officials said on Wednesday.
read article
Obamacare? Who Cares? There Are Drug Deals To Do
(Wall Street Journal Deal Blog) Mar 10, 2010 - Who cares about Obamacare? No matter how that Washington D.C. drama pans out, it is clear that pharmaceutical giants still remain desperate to fill up their drug pipelines.
read article (paid subscription required)
Medicare Regulators Halt Insurer's Part D Business
(BusinessWeek.com) Mar 10, 2010 - Federal regulators have banned an insurer from selling Medicare prescription drug coverage and accused it of improperly delaying and denying coverage of HIV, cancer and seizure medications.
read article
Scientists Identify MicroRNA as Possible Cause of Chemotherapy Resistance
(AACR) Mar 10, 2010 - Scientists may have uncovered a mechanism for resistance to paclitaxel in ovarian cancer, microRNA-31, suggesting a possible therapeutic target for overcoming chemotherapy resistance.
read press release
Seaweed Extract May Hold Promise for Non-Hodgkin’s Lymphoma Treatment
(AACR) Mar 10, 2010 - Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held here March 7-10, 2010.
read press release
Breast Cancer Incidence Among Iraqi Women Profiled
(AACR) Mar 10, 2010 - Breast cancer continues to rise in Iraq, and scientists have established the Iraqi National Cancer Research Program to better understand the underlying molecular and environmental causes in an effort to curb the incidence of cancer.
read press release
BioAlliance Announces Positive Preliminary Results in the First Phase I Clinical Trial of fentanyl Lauriad(R)
(CNBC.com) Mar 10, 2010 - Regulatory News: BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced positive preliminary results from the first Phase I trial of fentanyl Lauriad(R).
read article
Seattle Genetics Adds Patent to 2025
(Xconomy.com) Mar 11, 2010 - Seattle Genetics, the developer of antibody treatments for cancer, said today it has received a new patent which will extend its proprietary rights to its lead drug for Hodgkin’s disease until at least 2025.
read article
Bavarian Nordic Successfully Completes End of Phase II Meeting for PROSTVAC™
(Bavarian Nordic) Mar 9, 2010 – Bavarian Nordic A/S announced today that the company has received Scientific Advice from the European Medicines Agency and concluded an end of Phase II meeting with the US Food and Drug Administration (FDA) for the PROSTVAC™ programme.
read press release
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R)
(Yahoo! Finance) Mar 11, 2010 - Caraco Pharmaceutical Laboratories, Ltd. has launched oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, which are therapeutically equivalent to Eloxatin® from Sanofi-Aventis, received approval from the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA).
read article
Mayo Clinic Receives Unique Philanthropic Gift for Cancer Research
(Mayo Clinic) Mar 10, 2010 - Mayo Clinic is forming a new permanent professorship to augment cancer research that will focus on finding new treatments and preventive measures to reduce the incidence of cancer.
read press release
Sam Donaldson Named Inaugural Chair of NCCN Foundation Board
(NCCN) Mar 10, 2010 - The NCCN 15th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ commenced on Wednesday, March 10, 2010 with an announcement that veteran ABC news anchor Sam Donaldson has been named as chair of the newly established NCCN Foundation Board of Directors.
read press release
Transgene Sells Option on Cancer Vaccine to Novartis
(Bloomberg) Mar 10, 2010 - Transgene SA, the French biotechnology company backed by the billionaire Merieux family, sold Novartis AG an option on rights to the experimental TG4010 cancer vaccine in a deal that may fetch as much as $960 million.
read article
Virus Can Attack Prostate Cancer
(CBCNews.com) Mar 9, 2010 - Researchers in Alberta have successfully tested a new viral approach to treating prostate cancer in a small number of men. The study was published in Tuesday's online issue Cancer Research, a journal of the American Association for Cancer Research.
read article
Experiment Seeks Blood Test for Breast Cancer
(Reuters) Mar 9, 2010 - An experimental approach that looks for the DNA leaking out from dead and dying cells may provide a route to a blood test for breast cancer, U.S. researchers reported on Tuesday.
read article
Abbott Enhances Pharmaceutical Pipeline With Acquisition of Facet Biotech
(Yahoo! Finance) Mar 9, 2010 - Provides promising biologic intended to treat multiple sclerosis and compounds that complement Abbott's existing diverse oncology program.
read article
Research Findings Expected to Ease Treatment of Low Neutrophil Counts in Cancer Patients
(StreetInsider.com) Mar 10, 2010 - Multicenter trial led by St. Jude Children's Research Hospital investigators may change neutropenia treatment for all childhood cancer patients.
read article
Mayo Researchers Link Obesity to Worse Outcome in Patients Being Treated for Colon Cancer
(Mayo Clinic) Mar 9, 2010 - It's long been known that obesity is linked to increased risk of developing colon cancer, but now researchers at the Mayo Clinic campus in Minnesota have found that obesity is associated with worse outcomes in patients who have already been diagnosed and treated for the cancer.
read press release